You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company's CRISPR-chrom technology fuses chromatin-modulating peptides to CRISPR nucleases, essentially moving chromatin out of the way for more efficient editing.
In Science this week: genome of a wild wheatgrass that is resistant to fungal disease, and more.
Axxam said it will use the CRISPR technology to support the development of customized cell-based assays for targets and molecular pathways of interest.
GenomeWeb asked a number of prominent researchers in the field via email about their top picks for notable developments or achievements in genomics during the 2010s.
The Cas9 variant can target nearly all PAM sites in the genome, allowing the researchers to edit previously inaccessible disease-relevant genetic variants.
The screening platform, which uses the Cas13 nuclease to target RNA instead of DNA, can be used to design guide RNAs for CRISPR research.
The activity of the ABE8e editor is increased 590-fold compared to the activity of the ABE7.10, and it can be paired with a variety of Cas9 or Cas12 homologs.
Genes influencing NOTCH pathway activity were linked to head and neck squamous cell carcinoma with a mouse screen centered on genes with long tail mutations in human cases.
The company is in talks with potential partners in the US and China to validate the assay on clinical samples and deploy it at a large scale.
The company recently inked deals with Mammoth Biosciences and Rutgers University to license a protein discovery platform and gene editing technology.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.